-
11:49:48 PM

VRAX Stock News

04/19/23 7:30 AM
Nasdaq : VRAX
low float
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
About Virax Biolabs Group Limited. Founded in 2013, Virax Biolabs Group Limited is an innovative biotech company focused on the detection of immune responses to and diagnosis of viral diseases. In addition to distributing an array of in-vitro diagnostic test kits, Virax Biolabs Group Limited is currently developing a proprietary T-Cell Test technology...
RHEA-AI
neutral
03/10/23 5:17 PM
Nasdaq : VRAX
low float
Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Virax Biolabs Group Limited, an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, announced today the closing of its previously announced private placement of 3,843,309 ordinary shares, Series A preferred investment options to purchase up to an aggregate of 3,497,412 ordinary shares and Series B...
RHEA-AI
neutral
03/08/23 8:55 AM
Nasdaq : VRAX
low float
Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Virax Biolabs Group Limited, an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, announced today that it has entered into definitive agreements for the purchase and sale of 3,843,309 ordinary shares, Series A preferred investment options to purchase up to an aggregate of 3,497,412 ordinary shares and...
RHEA-AI
neutral
03/07/23 7:30 AM
Nasdaq : VRAX
low float
Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
Virax Biolabs Group Limited, an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, announced today that it has entered into an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to markets accepting the CE mark, namely the European Union. The test kit is for the detection and...
RHEA-AI
neutral
02/07/23 8:30 AM
Nasdaq : VRAX, COSM
covid-19low float
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)
Virax Biolabs Group Limited, an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, announced that it has signed a Purchase Order with Cosmos Health to launch and market COVID-19 and Influenza A+ B Antigen Combo Rapid Detection Kits. Pursuant to their previously signed distribution agreement dated...
RHEA-AI
neutral